Cargando…
Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery
AIM: The aim of this study was to determine intraoperative sedative and perioperative analgesic requirement and associated side effects of pregabalin (150 mg) for monitored anesthesia care during ear-nose-throat (ENT) surgeries. MATERIALS AND METHODS: The study design was randomized and single-blind...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490097/ https://www.ncbi.nlm.nih.gov/pubmed/28663620 http://dx.doi.org/10.4103/0259-1162.194589 |
_version_ | 1783246914743959552 |
---|---|
author | Kochhar, Anjali Banday, Jahanara Ahmad, Zainab Monga, Seema Vajifdar, Homay |
author_facet | Kochhar, Anjali Banday, Jahanara Ahmad, Zainab Monga, Seema Vajifdar, Homay |
author_sort | Kochhar, Anjali |
collection | PubMed |
description | AIM: The aim of this study was to determine intraoperative sedative and perioperative analgesic requirement and associated side effects of pregabalin (150 mg) for monitored anesthesia care during ear-nose-throat (ENT) surgeries. MATERIALS AND METHODS: The study design was randomized and single-blinded; fifty patients undergoing elective ambulatory ENT surgeries under monitored anesthesia care were randomly allocated to receive either placebo (Group P) or pregabalin (Group PG) 150 mg, orally 1 h before surgery. All patients were then given intravenous (i.v.) midazolam 2 mg and fentanyl 1 μg/kg and local anesthesia at the site. Sedation was induced by administering an i.v. bolus of propofol 0.8 mg/kg and was maintained by continuous infusion of propofol. Level of sedation was assessed by Ramsay scale, and propofol infusion was titrated accordingly. Intraoperative pain was assessed by verbal rating scale (VRS) score. Patient having VRS >4 or complaint of pain was given fentanyl (0.5 μg/kg) i.v. bolus. Intraoperative sedative and analgesic requirement were recorded. Postoperative visual analog scale scores and requirement of analgesics were recorded for the first 24 h after surgery. Diclofenac 75 mg intramuscular (i.m.) was administered as rescue analgesic. Side effects (nausea/vomiting, sedation, dizziness, blurred vision) were also recorded. RESULTS: Intraoperative propofol (212 ± 11 mg vs. 174 ± 9 mg; P = 0.013) and fentanyl (120 ± 8 μg vs. 94 ± 6 μg; P = 0.02) consumption was significantly lower in Group PG. Time to first analgesic request was longer (6.1 ± 0.4 h vs. 9.5 ± 1.2 h) with lesser requirement of analgesics (diclofenac) in the postoperative period. Incidence of side effects (sedation, nausea, vomiting) was found to be similar in both the groups. CONCLUSION: Premedication with pregabalin (150 mg) reduces intraoperative sedative and perioperative analgesic requirement in patients undergoing ENT surgeries under monitored anesthesia care with tolerable side effects. |
format | Online Article Text |
id | pubmed-5490097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-54900972017-06-29 Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery Kochhar, Anjali Banday, Jahanara Ahmad, Zainab Monga, Seema Vajifdar, Homay Anesth Essays Res Original Article AIM: The aim of this study was to determine intraoperative sedative and perioperative analgesic requirement and associated side effects of pregabalin (150 mg) for monitored anesthesia care during ear-nose-throat (ENT) surgeries. MATERIALS AND METHODS: The study design was randomized and single-blinded; fifty patients undergoing elective ambulatory ENT surgeries under monitored anesthesia care were randomly allocated to receive either placebo (Group P) or pregabalin (Group PG) 150 mg, orally 1 h before surgery. All patients were then given intravenous (i.v.) midazolam 2 mg and fentanyl 1 μg/kg and local anesthesia at the site. Sedation was induced by administering an i.v. bolus of propofol 0.8 mg/kg and was maintained by continuous infusion of propofol. Level of sedation was assessed by Ramsay scale, and propofol infusion was titrated accordingly. Intraoperative pain was assessed by verbal rating scale (VRS) score. Patient having VRS >4 or complaint of pain was given fentanyl (0.5 μg/kg) i.v. bolus. Intraoperative sedative and analgesic requirement were recorded. Postoperative visual analog scale scores and requirement of analgesics were recorded for the first 24 h after surgery. Diclofenac 75 mg intramuscular (i.m.) was administered as rescue analgesic. Side effects (nausea/vomiting, sedation, dizziness, blurred vision) were also recorded. RESULTS: Intraoperative propofol (212 ± 11 mg vs. 174 ± 9 mg; P = 0.013) and fentanyl (120 ± 8 μg vs. 94 ± 6 μg; P = 0.02) consumption was significantly lower in Group PG. Time to first analgesic request was longer (6.1 ± 0.4 h vs. 9.5 ± 1.2 h) with lesser requirement of analgesics (diclofenac) in the postoperative period. Incidence of side effects (sedation, nausea, vomiting) was found to be similar in both the groups. CONCLUSION: Premedication with pregabalin (150 mg) reduces intraoperative sedative and perioperative analgesic requirement in patients undergoing ENT surgeries under monitored anesthesia care with tolerable side effects. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5490097/ /pubmed/28663620 http://dx.doi.org/10.4103/0259-1162.194589 Text en Copyright: © 2016 Anesthesia: Essays and Researches http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Kochhar, Anjali Banday, Jahanara Ahmad, Zainab Monga, Seema Vajifdar, Homay Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery |
title | Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery |
title_full | Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery |
title_fullStr | Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery |
title_full_unstemmed | Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery |
title_short | Pregabalin in Monitored Anesthesia Care for Ear-nose-throat Surgery |
title_sort | pregabalin in monitored anesthesia care for ear-nose-throat surgery |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490097/ https://www.ncbi.nlm.nih.gov/pubmed/28663620 http://dx.doi.org/10.4103/0259-1162.194589 |
work_keys_str_mv | AT kochharanjali pregabalininmonitoredanesthesiacareforearnosethroatsurgery AT bandayjahanara pregabalininmonitoredanesthesiacareforearnosethroatsurgery AT ahmadzainab pregabalininmonitoredanesthesiacareforearnosethroatsurgery AT mongaseema pregabalininmonitoredanesthesiacareforearnosethroatsurgery AT vajifdarhomay pregabalininmonitoredanesthesiacareforearnosethroatsurgery |